Hims & Hers Health, Inc. (HIMS) Analyst Forecast

$47.91

$0.45 (0.95%)
Last update: 01:00 PM EST
Day's range
$46.55
Day's range
$49.06

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/24/2025 Truist Financial Jailendra Singh $45.00 $42.95   4.77%
06/04/2025 Needham Ryan Macdonald $65.00 $53.61   21.25%
02/19/2025 Canaccord Genuity Maria Ripps $68.00 $68.74   -1.08%
12/02/2024 Canaccord Genuity Maria Ripps $38.00 $30.81   23.34%
11/05/2024 Piper Sandler Korinne Wolfmeyer $21.00 $20.64   1.74%
11/05/2024 Needham Ryan MacDonald $28.00 $20.96   33.59%
10/29/2024 Leerink Partners Michael Cherny $26.00 $23.08   12.65%
10/21/2024 Bank of America Securities Michael Cherny $25.00 $22.15   12.87%
10/14/2024 Bank of America Securities Michael Cherny $23.00 $19.83   16.02%
10/14/2024 Truist Financial Jailendra Singh $23.00 $19.83   16.02%
09/13/2024 Bank of America Securities Allen Lutz $20.00 $15.82   26.42%
08/27/2024 Citigroup Daniel Grosslight $20.00 $14.93   34%
08/07/2024 Jefferies Glen Santangelo $18.00 $16.04   12.22%
08/06/2024 Deutsche Bank George Hill $23.00 $16.88   36.26%
05/22/2024 Canaccord Genuity Maria Ripps $24.00 $17.56   36.67%
05/07/2024 Jefferies Glen Santangelo $14.00 $12.35   13.36%
05/07/2024 Truist Financial Jailendra Singh $13.00 $12.41   4.8%
05/07/2024 Piper Sandler Korinne Wolfmeyer $13.00 $12.39   4.97%
05/07/2024 Deutsche Bank George Hill $16.00 $11.65   37.34%
04/15/2024 Jefferies Glen Santangelo $15.00 $13.22   13.46%
04/10/2024 Canaccord Genuity Maria Ripps $20.00 $14.55   37.46%

Hims & Hers Health, Inc. FAQ's

Hims & Hers Health, Inc. has been rated by research analysts at Truist Financial, UBS, Needham, Canaccord Genuity, Piper Sandler, Leerink Partners in the past 90 days.